Our website use cookies, which are necessary to its functioning and for analysing the traffic on our website. If you want to know more please refer to the privacy policy. You can opt-out cookies at any time by changing the settings of the browser you are using and deleting stored cookies. Find out more
Acino’s philosophy of diversity resonates with South Africa’s philosophy of equal opportunity, and we are extremely proud to have attained Level 1 B-BBEE status.
Monika leads Acino’s Bulk Production plants in Aesch and Liesberg, Switzerland. She works closely with our Contract Manufacturing team servicing B2B customers with best-in-class drug-delivery solutions for oral solid dosage forms.
We are currently all facing a time that we have never experienced before as individuals or as businesses; and are creating and adapting to new ways of living and working.
Acino and Takeda Pharmaceuticals announced today the completion of the acquisition for parts of Takeda’s primary care portfolio in selected countries in the Middle East, Africa, and Ukraine.
H.H. Sheikh Hamdan bin Rashid Al Maktoum, Deputy Ruler of Dubai and Minister of Finance of the United Arab Emirates, received Acino’s CEO Steffen Saltofte at the Zabeel palace in Dubai to review prospects for enhancing cooperation between Acino and the UAE.
Acino's manufacturing plant in Ukraine—Pharma Start—has successfully been certified according to the Good Manufacturing Practice of the European Union (EU GMP).
Acino is delighted to announce that it will begin commercial operations in Turkey.
Acino is proud to have been recognized as the Best Pharmaceutical Company 2019 for our contribution to the development of the country’s pharmaceutical industry, our high-quality medicines and successful cooperation with the Armenian healthcare community.
The partnership will see both companies provide respective services in the creation of high-quality pharmaceutical products.
Partnering with the Iraqi Hypertension Society (IHS), we support our commity in Iraq on World Heart Day.
Acino is proud to announce a partnership with the Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences.
Established in Switzerland since 1836 and with a proven track record of high quality products for many years the deeply rooted high standard quality pledge is reflected in all of Acino’s activities.
When you choose Acino, you are choosing quality you can rely on.
Our Mission is to develop, manufacture and commercialize Swiss quality pharmaceuticals for the benefit of patients.
Growing fast and making an impact for patients in emerging markets.
Who we are, what we stand for and are signposts for what we need to aspire to in our everyday actions.